Brainlab AG

Brainlab AG Overview

Brainlab AG, founded in 1989 and headquartered in Munich, Germany, is a global leader in medical technology and software, specializing in image-guided surgery, radiotherapy, and digital surgery solutions. The company was established by Stefan Vilsmeier, who remains its CEO. From its beginnings in Poing, near Munich, Brainlab has evolved into an international provider of cutting-edge surgical navigation and medical imaging solutions.

Company Background

Brainlab’s journey began with surgical planning and navigation software and has expanded into advanced hardware and digital platforms. In 2011, it acquired Voyant Health in Israel, later renamed Brainlab Israel. In 2017, Brainlab moved its headquarters to the historic Munich-Riem Airport site. In 2018, it acquired MINT Medical, a leader in imaging interpretation software, further strengthening its radiology and oncology portfolio.

Core Business and Products

• Surgical Navigation Systems: Including Cranial Navigation, Curve® Navigation, Kick® Navigation, and Kick® EM for neurosurgery and ENT, offering millimeter-level accuracy.

• Radiotherapy Platforms: The Novalis series and ExacTrac Dynamic system integrate AI, thermography, and X-ray localization for precision radiotherapy.

• Digital Surgery Room Solutions: Buzz® Digital O.R. integrates surgical devices, video streaming, and remote consultations; Quentry cloud supports secure global imaging exchange.

• Intraoperative Imaging & Robotics: Loop-X mobile 2D/3D imaging robot reduces radiation exposure, while Cirq™ robotic assistance supports minimally invasive surgery.

Market Position

Brainlab holds a 60% share in the global neurosurgical navigation market and is regarded as the gold standard in surgical navigation. Its technologies are installed in over 5,000 systems across 85 countries. In 2024, the company reported $330 million in revenue, with its solutions Included in guidelines by the American Society for Radiation Oncology.

Recent Developments

Brainlab’s Elements software platform now integrates AI for preoperative planning, intraoperative navigation, and rehabilitation. Although an IPO was initially planned in 2025 to raise €416 million, Brainlab postponed the offering due to market volatility, instead focusing on long-term strategic growth in orthopedics, sports medicine, cardiac surgery, and ENT.

Contact Information

Headquarters: Olof-Palme-Straße 9, Munich, Bavaria 81829, Germany
Phone: +49 89 9915680
Email: contact@brainlab.com